Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-6 and diabetes: the good, the bad, or the indifferent?

Diabetes - 1 Dec 2005

Kristiansen Ole P, Mandrup-Poulsen Thomas

Abstract excerpt

Inflammatory mechanisms play a key role in the pathogenesis of type 1 diabetes. Individuals who progress to type 2 diabetes display features of low-grade inflammation years in advance of disease onset. This low-grade inflammation has been proposed to be involved in the pathogenetic processes causing type 2 diabetes. Mediators of inflammation such as tumor necrosis factor-alpha, interleukin (IL)-1beta, the IL-6...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Diabetes Mellitus, Type 1
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation

Share to Insulin-Secreting Cells

Share to Interleukin-6

Share to Models, Genetic

Share to Signal Transduction

Source

Identifiers

PMID: 16306329
DOI: 10.2337/diabetes.54.suppl_2.s114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-6 and diabetes: the good, the bad, or the indifferent?PMID 16306329Read ↗

IL-6 signalling pathways and the development of type 2 diabetesSemantic proximity Read ↗

Interleukin-6 and its relation to inflammation and diseaseSemantic proximity Read ↗

Meta-analysis investigating the role of interleukin-6 mediated inflammation in type 2 diabetes.Semantic proximity Read ↗

Hall of Fame among Pro-inflammatory Cytokines: Interleukin-6 Gene and Its Transcriptional Regulation MechanismsSemantic proximity Read ↗

The interleukin 6 pathway and atherosclerosisSemantic proximity Read ↗

Role of Interleukins in Type 1 and Type 2 DiabetesSemantic proximity Read ↗

Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it mattersSemantic proximity Read ↗

Diabetes and inflammation: fundamental aspects and clinical implications.Semantic proximity Read ↗

The interleukin-6 pathway and atherosclerosis.Semantic proximity Read ↗

Genetic predispositions to low-grade inflammation and type 2 diabetes.Semantic proximity Read ↗

Interleukin-6-174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients.Semantic proximity Read ↗

Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.